Cargando…
Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer
BACKGROUND: The Hippo pathway is crucial in organ size control and tumorigenesis. Dysregulation of the Hippo/YAP axis is commonly observed in gastric cancer, while effective therapeutic targets for the Hippo/YAP axis are lacking. Identification of reliable drug targets and the underlying mechanisms...
Autores principales: | Wang, Tianshi, Wang, Dehai, Sun, Yanan, Zhuang, Ting, Li, Xin, Yang, Huijie, Zang, Yifeng, Liu, Ziping, Yang, Penghe, Zhang, Chenmiao, Cui, Jiayao, Fu, Mingxi, Zhang, Shuqing, Su, Peng, Li, Zhongbo, Zhu, Jian, Ding, Yinlu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636825/ https://www.ncbi.nlm.nih.gov/pubmed/37950281 http://dx.doi.org/10.1186/s13046-023-02870-3 |
Ejemplares similares
-
OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer
por: Yan, Cheng, et al.
Publicado: (2022) -
RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis
por: Li, Zhongbo, et al.
Publicado: (2022) -
DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer
por: Wang, Dehai, et al.
Publicado: (2022) -
USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis
por: Liu, Dongyi, et al.
Publicado: (2023) -
RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer
por: Yang, Huijie, et al.
Publicado: (2022)